Over 4.1 Billion Dollars in Results
The U.S. Food and Drug Administration (FDA) announced on Wednesday, May 9, that patients taking the osteoporosis drug, Fosamax, or any of the bone-building class of drugs known as bisphosphonates, should be reevaluated every three to five years to determine …
Continue Reading Even before it gets to court to defend itself against defective product charges over the DePuy metal hip, Johnson & Johnson (J&J) is defending itself in public. A British Medical Journal (BMJ) researcher, Deborah Cohen, who in February published a …
Continue Reading
If you blinked you may have missed this news item but it’s important to understand how government inaction hurts its citizens and this is a prime example. On Tuesday, May 8, a House subcommittee unanimously voted to approve its version …
Continue Reading Pradaxa, an anti-coagulant drug marketed by Boehringer Ingelheim Pharmaceuticals, enjoyed an unusually smooth (and quick) ride towards FDA approval. Rather than spending months pouring over clinical studies and safety data, FDA employees instead approved Pradaxa based primarily on a single …
Continue Reading With hundreds if not thousands of lawsuits filed against transvaginal mesh manufacturers, the first trial date has been set for cases to be heard against C.R. Bard Inc. February 5, 2013 is the first date set for bellwether trials filed …
Continue Reading So far this week, our firm has filed three new DePuy ASR hip implant cases in the MDL proceedings pending before Judge David A. Katz of the United States District Court in the Northern District of Ohio. These multi-district litigation …
Continue Reading There have been some significant developments in the bisphosphonate litigation over the past few months. Now that the two-year anniversary of the FDA’s safety alert over atypical femur fractures has passed, we anticipate that nearly 70 to 80% of the …
Continue Reading The Institute of Medicine (IOM) is taking the U.S. Food and Drug Administration (FDA) to task. In a new report, the IOM says the FDA should conduct more regular reviews of drugs to better catch and track safety issues. In …
Continue Reading The Top Ten of anything usually designates the ‘best’ but not in this case. An online report from Adverse Events Inc., an independent company that analyzes the FDA’s database of Adverse Event Reporting System (AERS), has just issued its Top …
Continue Reading I was thrilled to hear that some of our elected members of Congress are finally working on proactive legislation that might benefit all of us. This is especially encouraging after watching with much discouragement the high level of discord and …
Continue ReadingFlorida Personal Injury & Commercial Litigation Attorney Searcy Denney, PA: Home
Contact Medical Malpractice & Intellectual Property Lawyer: Searcy Denney Law Firm
© 2009 − 2011 All rights reserved.
